Frank Lupisella - C R Insider

C R Bard Inc -- USA Stock  

USD 327  2.46  0.76%

Principal Accounting Officer, VP and Controller

Mr. Frank Lupisella Jr., is Vice President, Controller of the Company. Mr. Lupisella joined Bard in 1987 and has served in various capacities in the finance organization of the company. Mr. Lupisella served as Vice President and Controller of the Davol division from 1999 until 2005 when he was promoted to Assistant Corporationrationrate Controller, Manufacturing Operations. In 2006, he was promoted to his present position of Vice President and Controller of the company.
Age: 55  VP Since 2006      
908 277-8000  www.crbard.com

Frank Lupisella Latest Insider Activity

Management Efficiency

The company has Return on Asset of 11.64 % which means that on every $100 spent on asset it made $11.64 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 32.96 % implying that it generated $32.96 on every 100 dollars invested.
The company has 1.66 B in debt with debt to equity (D/E) ratio of 89.3 . This implies that the company may be unable to create cash to meet all of its financial commitments. C R Bard Inc has Current Ratio of 1.55 which is typical for the industry and considered as normal.

Similar Executives

Found 8 records

VP Since

Donald BoboEdwards Lifesciences Corporatio
2007
John GallagherBecton Dickinson and Company
2014
Timothy LawrenceBaxter International Inc
2015
Jeanne MasonBaxter International Inc
2006
Sebastian BufalinoBaxter International Inc
N/A
Larry WoodEdwards Lifesciences Corporatio
2007
Patrick VerguetEdwards Lifesciences Corporatio
2004
David ScharfBaxter International Inc
2009

Entity Summary

C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. C R Bard Inc (BCR) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 14,900 people. C R is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Pair Correlation Now
   

Pair Correlation

Compare performance and examine historical correlation between any two equity instruments
Hide  View All  Next  Launch Pair Correlation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add C R Bard Inc to your portfolio

Top Management

C R Bard Leadership Team
James Beasley, President
Patricia Christian, President
Sharon Alterio, President
Todd Garner, President
Marc Breslawsky, Director
John Weiland, President, MBA
John DeFord, President
Frank Lupisella, VP
Betty Larson, President
John Groetelaars, President
Tony White, Director
Gerard Porreca, President
Robert Davis, Director, MBA
Anthony Welters, Director
Gail Naughton, Director, MBA
John Kelly, Director, MBA
Tommy Thompson, Director
Samrat Khichi, President
Sharon Luboff, President
Herbert Henkel, Director, MBA
Christopher Holland, CFO
David Melcher, Director
Jim Beasley, Executive
Timothy Collins, Executive
Timothy Ring, Chairman
David Barrett, Director

Stock Performance

C R Performance Indicators